CKD Associated with T2D
Understanding Albuminuria
Understanding Albuminuria
Albuminuria is associated with increased CV and renal risk and is an important marker for the early diagnosis of CKD associated with T2D.
Tabs header
Albuminuria and Early Diagnosis
Albuminuria is a crucial component of early identification and diagnosis of CKD associated with T2D.
Clinical Diagnosis of CKD in a patient with T2D
Albuminuria and Cardiorenal Outcomes
Albuminuria is associated with increased risk of CV events and CKD progression.
UACR Testing and Guidelines
Both UACR and eGFR should be used to guide CKD identification, monitoring, and appropriate management.
Guidelines recommend UACR to test for albuminuria in addition to eGFR at least annually in all patients with T2D starting at diagnosis

ADA, KDIGO, and AACE Guidelines
Recommend using both eGFR and UACR to properly identify, stage, and monitor CKD
in patients with T2D, as eGFR alone may miss the earlier stages of CKD1,6-8
Burden of Albuminuria
Increased albuminuria in patients with T2D burdens both the patient and the healthcare system.
~2-3x
higher costs for patients with UACR ≥30 mg/g
compared to patients with UACR <30 mg/g